It’s not the number of announcements, it’s what’s in them.
MNS often announces massive amounts of nothingness. Many of the releases are a few pages of info we either already knew, or “MOU” type situations which aren’t worth the paper they’re written on in most cases (for all companies not just MNS).
The NY delay is a big issue too IMO. There’s no financing set up, we don’t know exactly what’s going on behind the scenes, and as I predicted production got delayed. I bet a couple of users here that I’d never post again if they got production up by mid 2019. My prediction is end of 2020 for the first commercial battery off the line, that’s if they do finally get there. If this ends up being the case, there may need to be a CR in between to keep things moving.
Just my opinion based on the long history of delays with MNS.
MNS Chart, page-1328
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online